Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Case report

Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature

Authors: Vincent CC Cheng, Jonathan HK Chen, Josepha WM Tai, Sally CY Wong, Rosana WS Poon, Ivan FN Hung, Kelvin KW To, Jasper FW Chan, Pak-Leung Ho, Chung-Mau Lo, Kwok-Yung Yuen

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Prolonged asymptomatic carriage of vancomycin-resistant enterococci (VRE) in the gastrointestinal tract and the lack of effective decolonization regimen perpetuate the endemicity of VRE in the healthcare settings.

Case presentation

We report a regimen for decolonization of gastrointestinal carriage of VRE by a combination of environmental disinfection, patient isolation, bowel preparation to wash-out the fecal bacterial population using polyethylene glycol, a five-day course of oral absorbable linezolid and non-absorbable daptomycin to suppress any remaining VRE, and subsequent oral Lactobacillus rhamnosus GG to maintain the colonization resistance in four patients, including two patients with end-stage liver cirrhosis, one patient with complication post liver transplant, and one patient with complicated infective endocarditis. All patients had clearance of VRE immediately after decolonization, and 3 of them remained VRE-free for 23 to 137 days of hospitalization, despite subsequent use of intravenous broad-spectrum antibiotics without anti-VRE activity.

Conclusion

This strategy should be further studied in settings of low VRE endemicity with limited isolation facilities.
Appendix
Available only for authorised users
Literature
1.
go back to reference Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ: Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis. 2005, 11 (6): 821-828. 10.3201/1106.041204.CrossRefPubMedPubMedCentral Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ: Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis. 2005, 11 (6): 821-828. 10.3201/1106.041204.CrossRefPubMedPubMedCentral
2.
go back to reference Cheng VC, Tai JW, Chen JH, So SY, Ng WC, Hung IF, Leung SS, Wong SC, Chan TC, Chan FH, Ho PL, Yuen KY: Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc. 2014, 113 (10): 734-741. 10.1016/j.jfma.2014.04.001.CrossRefPubMed Cheng VC, Tai JW, Chen JH, So SY, Ng WC, Hung IF, Leung SS, Wong SC, Chan TC, Chan FH, Ho PL, Yuen KY: Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc. 2014, 113 (10): 734-741. 10.1016/j.jfma.2014.04.001.CrossRefPubMed
3.
go back to reference Cheng VC, Chan JF, Tai JW, Ho YY, Li I, To KK, Ho PL, Yuen KY: Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region. Emerg Health Threats J. 2009, 2: e9-PubMed Cheng VC, Chan JF, Tai JW, Ho YY, Li I, To KK, Ho PL, Yuen KY: Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region. Emerg Health Threats J. 2009, 2: e9-PubMed
4.
go back to reference Cheng VC, Tai JW, Ng ML, Chan JF, Wong SC, Li IW, Chung HP, Lo WK, Yuen KY, Ho PL: Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. Chin Med J (Engl). 2012, 125 (19): 3450-3457. Cheng VC, Tai JW, Ng ML, Chan JF, Wong SC, Li IW, Chung HP, Lo WK, Yuen KY, Ho PL: Extensive contact tracing and screening to control the spread of vancomycin-resistant Enterococcus faecium ST414 in Hong Kong. Chin Med J (Engl). 2012, 125 (19): 3450-3457.
5.
go back to reference Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM, Busuttil RW, Pegues DA: Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant. 2008, 8 (8): 1737-1743. 10.1111/j.1600-6143.2008.02304.x.CrossRefPubMed Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM, Busuttil RW, Pegues DA: Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant. 2008, 8 (8): 1737-1743. 10.1111/j.1600-6143.2008.02304.x.CrossRefPubMed
6.
go back to reference Cheng VC, Chan JF, Wong SC, Chen JH, Tai JW, Yan MK, Kwan GS, Tse H, To KK, Ho PL, Yuen KY: Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J (Engl). 2013, 126 (23): 4504-4509. Cheng VC, Chan JF, Wong SC, Chen JH, Tai JW, Yan MK, Kwan GS, Tse H, To KK, Ho PL, Yuen KY: Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J (Engl). 2013, 126 (23): 4504-4509.
7.
go back to reference O’Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RH: Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis. 1994, 18 (2): 105-109. 10.1016/0732-8893(94)90074-4.CrossRefPubMed O’Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RH: Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis. 1994, 18 (2): 105-109. 10.1016/0732-8893(94)90074-4.CrossRefPubMed
8.
go back to reference Chia JK, Nakata MM, Park SS, Lewis RP, McKee B: Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 1995, 21 (6): 1520-10.1093/clinids/21.6.1520.CrossRefPubMed Chia JK, Nakata MM, Park SS, Lewis RP, McKee B: Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 1995, 21 (6): 1520-10.1093/clinids/21.6.1520.CrossRefPubMed
9.
go back to reference Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM: Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 1999, 29 (2): 361-366. 10.1086/520216.CrossRefPubMed Weinstein MR, Dedier H, Brunton J, Campbell I, Conly JM: Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 1999, 29 (2): 361-366. 10.1086/520216.CrossRefPubMed
10.
go back to reference Mondy KE, Shannon W, Mundy LM: Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 2001, 33 (4): 473-476. 10.1086/321895.CrossRefPubMed Mondy KE, Shannon W, Mundy LM: Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 2001, 33 (4): 473-476. 10.1086/321895.CrossRefPubMed
11.
go back to reference Brossier F, Lefrancois S, Paute J, Gouot A, Golmard JL, Chaibi P, Pautas E, Berigaud S, Drieux L, Jarlier V, Aubry A: Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility. J Hosp Infect. 2010, 76 (4): 368-369. 10.1016/j.jhin.2010.06.020.CrossRefPubMed Brossier F, Lefrancois S, Paute J, Gouot A, Golmard JL, Chaibi P, Pautas E, Berigaud S, Drieux L, Jarlier V, Aubry A: Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility. J Hosp Infect. 2010, 76 (4): 368-369. 10.1016/j.jhin.2010.06.020.CrossRefPubMed
12.
go back to reference Hachem R, Raad I: Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2002, 23 (1): 43-44. 10.1086/501968.CrossRefPubMed Hachem R, Raad I: Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2002, 23 (1): 43-44. 10.1086/501968.CrossRefPubMed
13.
go back to reference Montecalvo MA: Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother. 2003, 51 (Suppl 3): iii31-iii35.PubMed Montecalvo MA: Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother. 2003, 51 (Suppl 3): iii31-iii35.PubMed
14.
go back to reference Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G, Fuchs HJ, Porter SB, Wenzel RP: Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis. 2001, 33 (9): 1476-1482. 10.1086/322687.CrossRefPubMed Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G, Fuchs HJ, Porter SB, Wenzel RP: Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis. 2001, 33 (9): 1476-1482. 10.1086/322687.CrossRefPubMed
15.
go back to reference Montecalvo MA, Horowitz H, Wormser GP, Seiter K, Carbonaro CA: Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 1995, 39 (3): 794-10.1128/AAC.39.3.794.CrossRefPubMedPubMedCentral Montecalvo MA, Horowitz H, Wormser GP, Seiter K, Carbonaro CA: Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 1995, 39 (3): 794-10.1128/AAC.39.3.794.CrossRefPubMedPubMedCentral
16.
go back to reference Eisenstein BI, Oleson FB, Baltz RH: Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis. 2010, 50 (Suppl 1): S10-S15.CrossRefPubMed Eisenstein BI, Oleson FB, Baltz RH: Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis. 2010, 50 (Suppl 1): S10-S15.CrossRefPubMed
17.
go back to reference Karki S, Cheng AC: Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect. 2012, 82 (2): 71-84. 10.1016/j.jhin.2012.07.005.CrossRefPubMed Karki S, Cheng AC: Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect. 2012, 82 (2): 71-84. 10.1016/j.jhin.2012.07.005.CrossRefPubMed
18.
go back to reference Szachta P, Ignys I, Cichy W: An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol. 2011, 45 (10): 872-877. 10.1097/MCG.0b013e318227439f.CrossRefPubMed Szachta P, Ignys I, Cichy W: An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol. 2011, 45 (10): 872-877. 10.1097/MCG.0b013e318227439f.CrossRefPubMed
19.
go back to reference de Regt MJ, Willems RJ, Hene RJ, Siersema PD, Verhaar HJ, Hopmans TE, Bonten MJ: Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother. 2010, 54 (7): 2801-2805. 10.1128/AAC.01765-09.CrossRefPubMedPubMedCentral de Regt MJ, Willems RJ, Hene RJ, Siersema PD, Verhaar HJ, Hopmans TE, Bonten MJ: Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother. 2010, 54 (7): 2801-2805. 10.1128/AAC.01765-09.CrossRefPubMedPubMedCentral
20.
go back to reference Manley KJ, Fraenkel MB, Mayall BC, Power DA: Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust. 2007, 186 (9): 454-457.PubMed Manley KJ, Fraenkel MB, Mayall BC, Power DA: Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust. 2007, 186 (9): 454-457.PubMed
21.
go back to reference Vidal M, Forestier C, Charbonnel N, Henard S, Rabaud C, Lesens O: Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol. 2010, 48 (7): 2595-2598. 10.1128/JCM.00473-10.CrossRefPubMedPubMedCentral Vidal M, Forestier C, Charbonnel N, Henard S, Rabaud C, Lesens O: Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol. 2010, 48 (7): 2595-2598. 10.1128/JCM.00473-10.CrossRefPubMedPubMedCentral
22.
go back to reference Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, Broyles J, Moore KL, Craig AS, Schaffner W: Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis. 2007, 13 (7): 1024-1030. 10.3201/eid1307.070019.CrossRefPubMedPubMedCentral Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, Broyles J, Moore KL, Craig AS, Schaffner W: Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis. 2007, 13 (7): 1024-1030. 10.3201/eid1307.070019.CrossRefPubMedPubMedCentral
23.
go back to reference Kelesidis T, Humphries R, Uslan DZ, Pegues DA: Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis. 2011, 52 (2): 228-234. 10.1093/cid/ciq113.CrossRefPubMed Kelesidis T, Humphries R, Uslan DZ, Pegues DA: Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis. 2011, 52 (2): 228-234. 10.1093/cid/ciq113.CrossRefPubMed
Metadata
Title
Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature
Authors
Vincent CC Cheng
Jonathan HK Chen
Josepha WM Tai
Sally CY Wong
Rosana WS Poon
Ivan FN Hung
Kelvin KW To
Jasper FW Chan
Pak-Leung Ho
Chung-Mau Lo
Kwok-Yung Yuen
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-514

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue